Suppr超能文献

琼脂培养物对恶性转化的选择性如何?

How selective are agar cultures for malignant transformation?

作者信息

Klein J C

出版信息

Arch Geschwulstforsch. 1981;51(1):58-62.

PMID:7259442
Abstract

In vitro assays that permit cloning of tumour cells in soft agar have been improved during the last 5 years. Two of them (2, 10) are claimed to be useful as test systems for the screening of new anticancer drugs and even for drug sensitivity testing of individual human tumours in the devicing of individualized cancer chemotherapy regimens. Three assays were investigated for this report: those of Toshio Kuroki (TK) (11) and Hamburger and Salmon (HS) (5, 10) and that in use for bone marrow cell cultures (BM) (3). Cells of various origins were tested for their growth capacity and colony formation in these three assays. Included were cells of 10 established lines classified as malignant or nonmalignant according to the in vivo malignancy test (6). Cells freshly derived from two tumours ans those from five tumours after 2-10 passages in monolayer culture were also used as test cells. The BM assay gave the best results. Up to now, a 100 per cent correlation has been found between the in vivo and in vitro test. Investigations are under way to determine whether this assay can also be used as a transformation assay using cells with a low transformation rate.

摘要

在过去5年中,允许在软琼脂中克隆肿瘤细胞的体外试验得到了改进。其中两种试验(2, 10)据称可作为筛选新抗癌药物的测试系统,甚至可用于在制定个体化癌症化疗方案时对个体人类肿瘤进行药物敏感性测试。本报告对三种试验进行了研究:黑木敏夫(TK)试验(11)、汉堡和萨蒙(HS)试验(5, 10)以及用于骨髓细胞培养的试验(BM)(3)。在这三种试验中测试了各种来源细胞的生长能力和集落形成情况。其中包括根据体内恶性试验(6)分类为恶性或非恶性的10个已建立细胞系的细胞。刚从两个肿瘤中获取的细胞以及在单层培养中传代2 - 10次后的五个肿瘤的细胞也用作测试细胞。BM试验给出了最佳结果。到目前为止,已发现体内和体外试验之间存在100%的相关性。正在进行研究以确定该试验是否也可作为使用低转化率细胞的转化试验。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验